In a few weeks we’ll be a quarter through the current century. It’s a good moment to draw some conclusions. 25 years is a ...

The company finished September with $1.9 billion in cash. A big cash pile gives CRISPR Therapeutics a long runway to ramp up ...

ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to ...

If humans can’t undergo such extreme lab tests, then why do animals have to go through such gruesome process? Are they any ...

New research from Australia's leading medical institute has found treating patients with high blood pressure is costing ...

Tom Yeung here with this week’s Sunday Digest. Many of you will know that I am a relatively conservative investor. I pay ...

Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...